On Mar. 29, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, announced it had awarded to fund numerous projects across the Agency’s discovery, clinical, and infrastructure programs.

The awards will support 11 projects in the Agency’s Foundation Awards (DISC 0) Program, which supports rigorous studies addressing critical basic knowledge gaps in the biology of stem cells and regenerative medicine approaches and to advance stem cell-based tools.

In addition, CIRM awarded $2.5 million to support the establishment of a Patient Support Program (PSP) to enhance patient access to CIRM-funded clinical trials, an important component of CIRM’s mission and Infrastructure Program.